Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Agrawal P, Bhagat D, Mahalwal M, Sharma N, Raghava GP (2021) AntiCP 2.0: an updated model for predicting anticancer peptides
"There are many options for patients." She adds that the authors are joining with the American Academy of Ophthalmology in recommending a post-marketing survey to more accurately assess the number of patients receiving these drugs who experience an adverse ocular reaction
*PLoS ONE*, 8(12), e79913
Consumers Taking GLP-1s for Weight Loss, Current or Discontinued, Drive Lasting Changes in Retail, Per New Acosta Group Study News provided by Acosta Group Apr 14, 2025, 12:05 ET 76% of those who discontinued GLP-1s are eating the same amount or less and many report retaining healthy habits JACKSONVILLE, Fla., April 14, 2025 /PRNewswire/ -- In advance of the National Association of Chain Drug Stores (NACDS) Annual Meeting, Acosta Group is sharing the results of its recent proprietary GLP-1 Shopper Community study, focusing on consumers using the medications specifically to support weight loss
US$ 24.98
US$ 27.58
US$ 27.30
